Zurich Cantonal Bank’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Other funds holding PDLI
SPC
PWAM
GCIA
JC
Zurich Cantonal Bank's PDLI Position: Q4 2020 in Review
Zurich Cantonal Bank sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 15,690 shares — an estimated $49K sold.
Zurich Cantonal Bank first reported a position in PDLI in Q3 2013 and held it in 24 quarters. The position peaked at $221K in Q3 2013. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.
- Zurich Cantonal Bank reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
- Zurich Cantonal Bank sold 15,690 PDL BioPharma, Inc. shares in Q4 2020, an estimated $49K.
- Zurich Cantonal Bank first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 24 quarters.
- Zurich Cantonal Bank's PDL BioPharma, Inc. position peaked at $221K in Q3 2013.
- 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.
Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.